Q8BYY9
Gene name |
Serpina3b |
Protein name |
Serine protease inhibitor A3B |
Names |
Serpin A3B |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:271047 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8BYY9
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8BYY9-F1 | Predicted | AlphaFoldDB |
58 variants for Q8BYY9
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs254409947 | 13 | E>G | No | EVA | |
| rs3403442368 | 18 | V>A | No | EVA | |
| rs3403681335 | 21 | C>N | No | EVA | |
| rs33096095 | 58 | F>L | No | EVA | |
| rs3389271708 | 61 | E>* | No | EVA | |
| rs3389243433 | 70 | N>S | No | EVA | |
| rs232756296 | 76 | F>V | No | EVA | |
| rs253481732 | 81 | A>S | No | EVA | |
| rs33096098 | 85 | L>F | No | EVA | |
| rs243808646 | 111 | A>S | No | EVA | |
| rs46608050 | 118 | K>E | No | EVA | |
| rs47107255 | 118 | K>R | No | EVA | |
| rs262573443 | 178 | I>V | No | EVA | |
| rs224234950 | 186 | T>I | No | EVA | |
| rs33096896 | 197 | M>L | No | EVA | |
| rs252591946 | 203 | M>V | No | EVA | |
| rs3403238499 | 205 | I>M | No | EVA | |
| rs45861189 | 208 | D>E | No | EVA | |
| rs3403984048 | 209 | L>I | No | EVA | |
| rs49284200 | 210 | F>L | No | EVA | |
| rs3403005862 | 212 | K>T | No | EVA | |
| rs3389260695 | 214 | E>G | No | EVA | |
| rs3389190271 | 214 | E>Q | No | EVA | |
| rs29145410 | 216 | M>K | No | EVA | |
| rs3389252913 | 217 | V>M | No | EVA | |
| rs213899934 | 222 | D>N | No | EVA | |
| rs238969757 | 230 | I>K | No | EVA | |
| rs252289450 | 236 | H>R | No | EVA | |
| rs3389255790 | 261 | V>M | No | EVA | |
| rs3389255650 | 266 | Y>* | No | EVA | |
| rs3413093363 | 271 | K>M | No | EVA | |
| rs3403737775 | 271 | K>N | No | EVA | |
| rs3403681350 | 271 | K>Q | No | EVA | |
| rs3389216794 | 279 | Q>L | No | EVA | |
| rs254997094 | 291 | P>S | No | EVA | |
| rs254997094 | 291 | P>T | No | EVA | |
| rs217969040 | 292 | G>E | No | EVA | |
| rs3389258754 | 298 | R>K | No | EVA | |
| rs3402301496 | 305 | K>M | No | EVA | |
| rs3403442394 | 307 | K>E | No | EVA | |
| rs3389271710 | 307 | K>N | No | EVA | |
| rs3403845242 | 310 | H>Y | No | EVA | |
| rs3389255648 | 320 | Y>* | No | EVA | |
| rs3403681340 | 354 | E>Q | No | EVA | |
| rs1133575800 | 355 | M>I | No | EVA | |
| rs3389243426 | 355 | M>L | No | EVA | |
| rs1134846152 | 356 | I>V | No | EVA | |
| rs1133889307 | 359 | T>A | No | EVA | |
| rs1132360762 | 360 | E>V | No | EVA | |
| rs1132689656 | 366 | K>Q | No | EVA | |
| rs1133949084 | 366 | K>T | No | EVA | |
| rs1132423058 | 370 | G>A | No | EVA | |
| rs1134949776 | 377 | G>E | No | EVA | |
| rs1133063608 | 379 | N>D | No | EVA | |
| rs1135267838 | 381 | M>L | No | EVA | |
| rs3389249951 | 392 | F>I | No | EVA | |
| rs214768149 | 409 | H>Y | No | EVA | |
| rs232426754 | 410 | V>L | No | EVA |
No associated diseases with Q8BYY9
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| serine-type endopeptidase inhibitor activity | Binds to and stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme. |
1 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of endopeptidase activity | Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins. |
37 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q9N2I2 | SERPINA5 | Plasma serine protease inhibitor | Bos taurus (Bovine) | PR |
| P41361 | SERPINC1 | Antithrombin-III | Bos taurus (Bovine) | PR |
| Q1JPB0 | SERPINB1 | Leukocyte elastase inhibitor | Bos taurus (Bovine) | PR |
| P13909 | SERPINE1 | Plasminogen activator inhibitor 1 | Bos taurus (Bovine) | PR |
| Q9TTE1 | SERPINA3-1 | Serpin A3-1 | Bos taurus (Bovine) | PR |
| A2I7N1 | SERPINA3-5 | Serpin A3-5 | Bos taurus (Bovine) | PR |
| A6QPQ2 | SERPINA3-8 | Serpin A3-8 | Bos taurus (Bovine) | PR |
| A2I7N2 | SERPINA3-6 | Serpin A3-6 | Bos taurus (Bovine) | PR |
| A2I7M9 | SERPINA3-2 | Serpin A3-2 | Bos taurus (Bovine) | PR |
| O73790 | SERPINB10 | Heterochromatin-associated protein MENT | Gallus gallus (Chicken) | PR |
| P05121 | SERPINE1 | Plasminogen activator inhibitor 1 | Homo sapiens (Human) | PR |
| Q9UK55 | SERPINA10 | Protein Z-dependent protease inhibitor | Homo sapiens (Human) | PR |
| P05155 | SERPING1 | Plasma protease C1 inhibitor | Homo sapiens (Human) | PR |
| P08697 | SERPINF2 | Alpha-2-antiplasmin | Homo sapiens (Human) | PR |
| Q86WD7 | SERPINA9 | Serpin A9 | Homo sapiens (Human) | PR |
| P01008 | SERPINC1 | Antithrombin-III | Homo sapiens (Human) | PR |
| P07093 | SERPINE2 | Glia-derived nexin | Homo sapiens (Human) | PR |
| Q96P15 | SERPINB11 | Serpin B11 | Homo sapiens (Human) | PR |
| P01011 | SERPINA3 | Alpha-1-antichymotrypsin | Homo sapiens (Human) | PR |
| P12388 | Serpinb2 | Plasminogen activator inhibitor 2, macrophage | Mus musculus (Mouse) | PR |
| P32261 | Serpinc1 | Antithrombin-III | Mus musculus (Mouse) | PR |
| Q07235 | Serpine2 | Glia-derived nexin | Mus musculus (Mouse) | PR |
| Q5SV42 | Serpinb1c | Leukocyte elastase inhibitor C | Mus musculus (Mouse) | PR |
| Q80X76 | Serpina3f | Serine protease inhibitor A3F | Mus musculus (Mouse) | PR |
| Q9D154 | Serpinb1a | Leukocyte elastase inhibitor A | Mus musculus (Mouse) | PR |
| Q9JK88 | Serpini2 | Serpin I2 | Mus musculus (Mouse) | PR |
| Q8CDC0 | Serpinb13 | Serpin B13 | Mus musculus (Mouse) | PR |
| P22777 | Serpine1 | Plasminogen activator inhibitor 1 | Mus musculus (Mouse) | PR |
| Q5I2A0 | Serpina3g | Serine protease inhibitor A3G | Mus musculus (Mouse) | PR |
| P29524 | Serpinb2 | Plasminogen activator inhibitor 2 type A | Rattus norvegicus (Rat) | PR |
| Q6P734 | Serping1 | Plasma protease C1 inhibitor | Rattus norvegicus (Rat) | PR |
| P05545 | Serpina3k | Serine protease inhibitor A3K | Rattus norvegicus (Rat) | PR |
| P07092 | Serpine2 | Glia-derived nexin | Rattus norvegicus (Rat) | PR |
| Q62975 | Serpina10 | Protein Z-dependent protease inhibitor | Rattus norvegicus (Rat) | PR |
| O48706 | At2g26390 | Serpin-Z3 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q9M1T7 | At3g45220 | Serpin-Z4 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q9ZQR6 | At2g14540 | Serpin-Z2 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAFIAALGLL | MAEICPAVIC | CSDGTLGMHN | AVQKGQDTQK | QLDSLTLASI | NTDFAFSFYK |
| 70 | 80 | 90 | 100 | 110 | 120 |
| ELALKNPHKN | IAFSPFGIAT | ALNSLTLGAK | GNTLEEILEV | LKFNLTETSE | ADIHQGFKHL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LQRLSHPGDQ | VQIRTGNALF | VEKHLQILAE | FKEKARALYH | TEVFTANFQQ | PHEAMKLINS |
| 190 | 200 | 210 | 220 | 230 | 240 |
| YMSNQTQGKI | KELVSDMDGN | TSMVIVNDLF | FKAEWMVPFN | SDDTFMGKFI | VDRSRHVKVP |
| 250 | 260 | 270 | 280 | 290 | 300 |
| MMKTKNLRTP | YFRDEELKCT | VVELNYKGNG | KAMFILPDQG | KMQQVEASLQ | PGTLKKWRKS |
| 310 | 320 | 330 | 340 | 350 | 360 |
| LRPRKIKELH | LPKFSLSQHY | NLEDILPELG | IRELFSTQAD | LSGITGVKNI | TVSEMIHSTE |
| 370 | 380 | 390 | 400 | 410 | |
| LDMTEKGTEG | DAITIVGYNF | MSAKLKPVFV | KFEDQFLYIV | LDQGDLWIHV | MGKVINPSEK |